Opioid talks at impasse; Purdue bankruptcy filing expected
CLEVELAND — OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation’s deadly overdose crisis hit an impasse, attorneys general involved in the talks said Saturday in a message to their counterparts across the country.
The breakdown puts the first federal trial over the opioid epidemic on track to begin next month and sets the state for a complex legal drama involving more than 30 states and 2,000 local governments.
Purdue, its owners, the Sackler family, and a group of state attorneys general had been trying for months to find a way to avoid trial and determine Purdue’s responsibility for a crisis that has cost 400,000 American lives over the past two decades.
The email from the attorneys general of Tennessee and North Carolina said that Purdue and the Sacklers had rejected two offers from the states over how payments under any settlement would be handled and that the family declined to offer counterproposals.